Dr. Reddy’s is in focus as reports from Bloomberg suggest Sputnik V could receive emergency approval in India from the first week of March.
Post Q3, Dr. Reddy’s had indicated applying for emergency approval by March 2021. According to analysts, the chances of Dr. Reddy’s receiving approval are quite high considering that they have already received approval in 26 countries.
Dr. Reddy’s is conducting phase III trials in India and have also tied up with distribution for the vaccine. They will have access to the first 125 million doses of the vaccine.
Watch the video for more